{"id":"at02","safety":{"commonSideEffects":[{"rate":"null","effect":"Increased risk of genital yeast infections"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting SGLT2, AT02 reduces glucose reabsorption in the kidneys, leading to decreased blood glucose levels. This mechanism is particularly useful in the treatment of type 2 diabetes.","oneSentence":"AT02 is a small molecule that targets the SGLT2 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:21:43.585Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT07140536","phase":"NA","title":"The Impact of Treadmills and Cooler Environments for Office Workplaces on Ergonomics, Heating Energy Requirements, Performance, as Well as Back and Cardiometabolic Health","status":"COMPLETED","sponsor":"RWTH Aachen University","startDate":"2025-07-03","conditions":"Healthy Male and Female Subjects","enrollment":16},{"nctId":"NCT05938036","phase":"PHASE2","title":"Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aqualung Therapeutics Corp.","startDate":"2023-12-01","conditions":"Acute Respiratory Distress Syndrome (ARDS)","enrollment":15},{"nctId":"NCT07217769","phase":"NA","title":"Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-06-01","conditions":"Shift Work","enrollment":130},{"nctId":"NCT05951049","phase":"PHASE2","title":"A Study of AT-02 in Subjects With Systemic Amyloidosis.","status":"RECRUITING","sponsor":"Attralus, Inc.","startDate":"2023-09-21","conditions":"Amyloidosis; Systemic","enrollment":120},{"nctId":"NCT06342674","phase":"NA","title":"Effect of Breast Milk Circadian Properties on Infant's Growth Parameters and Absorption of Nutrients","status":"RECRUITING","sponsor":"Sakarya University","startDate":"2024-01-25","conditions":"Breast Feeding, Breast Milk Collection","enrollment":44},{"nctId":"NCT05521022","phase":"PHASE1","title":"Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis","status":"RECRUITING","sponsor":"Attralus, Inc.","startDate":"2022-09-01","conditions":"Amyloidosis; Systemic","enrollment":100},{"nctId":"NCT00788229","phase":"PHASE2","title":"Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome","status":"COMPLETED","sponsor":"Dhp Korea Co., Ltd.","startDate":"2008-11","conditions":"Dry Eye Syndromes, Keratoconjunctivitis Sicca","enrollment":72}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DHP-300"],"phase":"phase_2","status":"active","brandName":"AT02","genericName":"AT02","companyName":"Dhp Korea Co., Ltd.","companyId":"dhp-korea-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AT02 is a small molecule that targets the SGLT2 receptor. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}